Clinical Trial Update: Phase 3 Study to Evaluate the Safety and Efficacy of Galnobax® in Treating Diabetic Foot Ulcers [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Galnobax for diabetic foot ulcers has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• Galnobax

Snippet

Sponsor: Novalead Pharma Private Limited | Conditions: Diabetic Foot Ulcer | Phase 3 | Status: COMPLETED | Results posted: 2023-09-22